drugset / Trial / NCT01494740
Immunogenicity and Safety of an Inactivated Split-virion 2009 Pandemic Influenza A H1N1 Vaccine in Infants
RandomizedParallel-groupQuadruple-blindPrevention
Summary
The aim of this study is to investigate the immunogenicity and safety of the inactivated split-virion vaccine in infants.
Timeline
- Start
- 2009-12
- Primary completion
- 2010-01
- Completion
- 2010-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | split-virion, non-adjuvanted H1N1 vaccine | Vaccine | 7.5 ug | — |
| Subject | split-virion, non-adjuvanted H1N1 vaccine | Vaccine | 15 ug | — |
| Subject | split-virion, non-adjuvanted seasonal influenza vaccine | Vaccine | — | — |